Skip to main content
This site provides educational information only, not medical advice. Always consult a qualified healthcare provider.
Hormonal Comorbidity

HS and PCOS: The Hormonal Connection

Polycystic ovary syndrome and hidradenitis suppurativa share deep hormonal and metabolic roots. Understanding this connection can unlock better treatment for both conditions.

Last reviewed: April 2026|10 min read

Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making changes to your treatment plan.

Key Takeaway

Women with PCOS are significantly more likely to develop HS than those without PCOS. Both conditions are driven by androgen excess and insulin resistance, meaning that treatments targeting hormones or metabolic function - such as spironolactone, metformin, or anti-androgenic contraceptives - can benefit both conditions simultaneously.

Why They Co-Occur

Shared Biological Mechanisms

PCOS and HS are not simply two conditions that happen to occur together - they share overlapping biological pathways that cause and reinforce each other.

Androgen Excess

Both PCOS and HS are driven by elevated androgens. In PCOS, the ovaries produce excess testosterone and DHEA-S. These androgens stimulate the apocrine and sebaceous glands in the skin, promoting the follicular plugging and gland rupture that trigger HS lesions. Women with PCOS who have HS often have measurably higher androgen levels than those with HS alone.

Insulin Resistance

Insulin resistance is a hallmark of PCOS and is increasingly recognized as a contributing factor in HS. High insulin levels stimulate ovarian androgen production and promote systemic inflammation. Metformin, which improves insulin sensitivity, has shown benefit in reducing HS flare frequency in several clinical studies.

Chronic Inflammation

Both conditions involve elevated pro-inflammatory cytokines including TNF-alpha, IL-1beta, and IL-6. This shared inflammatory environment means that controlling inflammation in one condition may benefit the other. Biologics that target TNF-alpha (like adalimumab) or IL-17 (like secukinumab) may also reduce systemic inflammation relevant to PCOS.

Microbiome Disruption

Emerging research suggests that gut microbiome dysbiosis - an imbalance in gut bacteria - may link PCOS and HS. Both conditions are associated with altered gut flora that promotes systemic inflammation and hormone dysregulation. Dietary interventions that support gut health may benefit both conditions.

Symptom Overlap

Symptoms: What Overlaps and What Differs

Some symptoms are unique to each condition; others are shared. Understanding the overlap helps you and your doctors identify which condition is driving each symptom.

SymptomPCOSHS
Irregular or absent periodsYes-
Excess facial or body hair (hirsutism)Yes-
Acne (face, chest, back)Yes-
Painful nodules in skin folds-Yes
Draining tunnels (sinus tracts)-Yes
Scarring in affected areas-Yes
Fatigue and low energyYesYes
Weight gain or difficulty losing weightYesYes
Mood changes, depression, anxietyYesYes
Elevated androgens on blood testsYesYes
Treatment

Treatments That Address Both Conditions

Because PCOS and HS share hormonal and metabolic drivers, several treatments can improve both conditions at once. A coordinated approach between your dermatologist and gynecologist or endocrinologist is ideal.

Spironolactone

Anti-Androgen

An anti-androgen medication that blocks androgen receptors. Used in PCOS for hirsutism and acne, and increasingly used off-label for HS in women. Reduces androgen-driven flares in both conditions.

Metformin

Insulin Sensitizer

Improves insulin sensitivity and reduces ovarian androgen production. Several small studies show reduced HS flare frequency. Particularly useful in patients with both PCOS and metabolic syndrome.

Combined Oral Contraceptives

Hormonal

Pills containing anti-androgenic progestins (drospirenone, cyproterone acetate) suppress ovarian androgen production and regulate periods. Can reduce androgen-driven HS flares in women with PCOS.

Biologics (Adalimumab, Secukinumab)

Biologic Therapy

FDA-approved for moderate-to-severe HS. Target specific inflammatory pathways (TNF-alpha, IL-17). Also reduce systemic inflammation relevant to PCOS. Require specialist prescription and monitoring.

Anti-Inflammatory Diet

Lifestyle

A low-glycemic, anti-inflammatory diet reduces insulin spikes, lowers androgen levels, and may reduce HS flare frequency. Particularly beneficial for patients with both PCOS and HS. Dairy and high-glycemic foods are common triggers for both conditions.

FAQ

Frequently Asked Questions

References

  1. 1.Kromann CB, et al. The influence of body weight on the prevalence and severity of hidradenitis suppurativa. Acta Derm Venereol. 2014;94(5):553-557. PubMed
  2. 2.Garg A, et al. Prevalence and co-morbidities of hidradenitis suppurativa in the United States. Dermatology. 2014;228(3):261-265. PubMed
  3. 3.Verdolini R, et al. Metformin in the treatment of hidradenitis suppurativa: a little help along the way. J Eur Acad Dermatol Venereol. 2013;27(9):1101-1108. PubMed
  4. 4.Alikhan A, et al. North American clinical management guidelines for hidradenitis suppurativa. J Am Acad Dermatol. 2019;81(1):76-90. PubMed
  5. 5.Teede HJ, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602-1618. PubMed
  6. 6.Bukvic Mokos Z, et al. Understanding the relationship between smoking and hidradenitis suppurativa. Acta Dermatovenerol Croat. 2020;28(1):9-13. PubMed